Mads Jorgen Nohr Clausen
Président chez Clausen Controls Holding Ii ApS
Profil
Mads Jorgen Nohr Clausen is associated with Clausen Controls Holding II ApS as Chairman since 2022 and with MC2 Therapeutics Ltd.
as Director since 2008.
Postes actifs de Mads Jorgen Nohr Clausen
| Sociétés | Poste | Début |
|---|---|---|
MC2 Therapeutics Ltd.
 MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Directeur/Membre du Conseil | 25/06/2008 |
Clausen Controls Holding Ii ApS
 Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Président | 04/05/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MC2 Therapeutics Ltd.
MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Health Technology |
Clausen Controls Holding Ii ApS
Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Finance |
